umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Umeå University, Faculty of Medicine, Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2004 (English)In: Stroke, ISSN 1524-4628, Vol. 35, no 10, 2418-24 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 35, no 10, 2418-24 p.
Keyword [en]
Cerebrovascular Accident/*drug therapy, Data Interpretation; Statistical, Fibrinolytic Agents/*therapeutic use, Humans, Randomized Controlled Trials, Risk, Tissue Plasminogen Activator/*therapeutic use, Treatment Outcome
Identifiers
URN: urn:nbn:se:umu:diva-12983DOI: doi:10.1161/01.STR.0000140891.70547.56PubMedID: 15345796OAI: oai:DiVA.org:umu-12983DiVA: diva2:152654
Available from: 2007-04-26 Created: 2007-04-26 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15345796&dopt=Citation

Search in DiVA

By author/editor
Asplund, Kjell
By organisation
Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 53 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf